Life Changing Ideas. Game Changing Support.

Experience life as part of one of the most successful locations for life science start-ups in Europe. If you are an early-career entrepreneur with a sustainable business proposition based on great science and have the imagination, creativity, and resilience to succeed, Accelerate@Babraham is the place for you.

APPLICATIONS NOW OPEN

Discover more

5 Month Programme

Concentrated, intense, potentially life-changing

5 Life Science Start-ups

A competitive and rigorous selection process - only 5 will make it

Lab Space & Equipment

Access to free lab space and support to stress test your science

Expert Mentoring & Support

Challenge and be challenged by those that have been there and done it before

£10,000 Cash Prize

No strings attached non-dilutive funding, spend it wisely!

Today’s experts supporting tomorrow’s innovators

Founded and developed at the Babraham Research Campus, Accelerate@Babraham was created out of a desire to support and nurture early-stage life science ventures attempting to navigate this tough and fast-moving sector.

The initiative is personal - many of those involved in delivering the programme have been there themselves, many times. The experiences of this group of incredibly skilled life science experts and mentors, combined with the additional wrap-around support, is what sets Accelerate@Babraham apart.

Read more

Start-up Story

Want to know what life as part of Accelerate@Babraham is really like? We sat down with previous participants to understand just that. The resulting article and film will give you an insight into the value of the programme, the incredible team of partners and supporters that are involved in delivering it and the tangible successes achieved by our cohort companies.

Read more

APPLY NOW!

Applications now open!

Applications for the 2022/23 Accelerate@Babraham cohort are now open. Just five companies will make it through to the five-month bio-entrepreneurial programme, and each slot will be hotly contested via a rigorous competitive application and pitching process. Watch this space to find out who makes it through!

Apply Now

Strategic Partners

Accelerate@Babraham wouldn’t exist without the commitment and support of a superb group of strategic supporters, all of whom dedicate time, resource, and funds to ensure the initiative is continually able to evolve and adapt to deliver the very best nurturing support, not only to the current cohort but also the alumni.

Expertise

Mentors & Experts

Over 60 individuals, all highly experienced in their respective fields, give their time freely in support of our next generation life science innovators. To date we’ve delivered over 130 bespoke training sessions, facilitated over 330 hours of round-table seminars and discussions, and made hundreds of personal introductions. Meet them here.

Read more

}

Latest News & Insights

Since launching in 2018 we have supported 20 companies. To date, our alumni has raised a total investment of £12.5m and we proudly shout about their successes and achievements whenever and wherever we can!

Cambridge irons out the wrinkles in anti-ageing science arena

Cambridge irons out the wrinkles in anti-ageing science arena

Cambridge is playing a lead role in developing technology designed to rejuvenate skin cells and arrest the march of age-related diseases.

Read more

Shift Bioscience is hiring!

Shift Bioscience is hiring!

The longevity biotech company using machine learning to develop therapeutics for safe cellular reprogramming has three open positions.

Read more

From ‘a metaphorical slap around the face’ to ‘life-saving’ - how life science start-ups view Accelerate@Babraham

From ‘a metaphorical slap around the face’ to ‘life-saving’ - how life science start-ups view Accelerate@Babraham

The latest cohort of five life science start-ups to complete the 2021/22 cycle of Accelerate at Babraham may have had the added pressure of a pandemic throughout the five-month programme but all made great strides to develop their business propositions, which in turn promises to change patient outcomes.

Read more